failed BE study [Regulatives / Guidelines]

posted by Dr_Dan  – Germany, 2010-06-03 11:21 (5871 d 00:22 ago) – Posting: # 5422
Views: 7,625

Dear ElMaestro
Thanks for your reply. I agree that this issue will be assessed differently across EU countriesit and surely it will be a great difference whether or not the product is submitted in a dcp or nationally. Actually I have the following problem: 3 studies, US fasted and fed bioequivalent, EU failed (upper CI for Cmax 125.1%). US and EU reference have a different formulation, test was the same. Failed EU study: Point estimator for Cmax 117%, for AUC 87% => test and reference different formulations with different PK. Honestly I see no chance. Do you agree that a second BE study would not convince the assessor even if bioequivalence is shown?
Kind regrads
Dan

Kind regards and have a nice day
Dr_Dan

Complete thread:

UA Flag
Activity
 Admin contact
23,656 posts in 4,994 threads, 1,570 registered users;
312 visitors (0 registered, 312 guests [including 15 identified bots]).
Forum time: 11:44 CEST (Europe/Vienna)

It requires a very unusual mind
to undertake the analysis of the obvious.    Alfred North Whitehead

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5